, Iffat Raza 5 ABSTRACT… Background: The study was designed to evaluate short term effects of commonly used antidiabetic drugs on liver. The objective of the study is to observe and analyze the correlation between percent liver weight and percent liver fat cells in control rats and diabetic, insulin, metformin and insulin-metformin combination treated high fat diet (HFD) / Streptozotocin (STZ) induced diabetic albino rats. Study Design: Experimental comparative study. Setting: Institute of Bio Medical Sciences (IBMS), Dow University of Health Sciences (DUHS), Ojha Campus, Karachi. Period: December 2014 to May 2015. Materials and Methods: The experimental study was conducted on 50 albino wistar rats. 10 rats served as control rats while rest of the rats were experimentally induced for diabetes type 2 and were then randomized into 5 groups. One group was treated with insulin, one with metformin, and the one group with insulin-metformin combination for 4 weeks. All the treated groups were compared with untreated and control group. At the end of experiment, all the rats were sacrificed and livers were isolated and weighed. Percent liver weight calculated. Liver cut sections were processed and stained to analyze the correlation in percent fat cells in liver percent liver weight and in each treated and untreated diabetic groups, then the results were compared with control rats. Results: Data is analyzed by using SPSS Version 22. Pearson correlation was used to identify correlation between the percent liver weight and percent fat cells in liver of control, treated and untreated diabetic groups. Significant and positive correlation (p-value < 0.01) in insulin treated group of diabetic rats was observed indicating that insulin has a role in causing fatty liver. Conclusion: Insulin treated diabetic group shows a significant positive correlation between percent fat cells of liver and percent liver weight.
INTRODUCTION
We fortunately or unfortunately are living in modernized era where unhealthy dietary habits and physical inactivity can be considered as a keystone for all diseases. Use of high fat food and lack of exercise give birth to obesity leading to resistance to insulin (IR) and ending up with a lot more diseases. Fatty liver disease in diabetics remains unnoticed because of its silent course. There is strong association of IR with diabetes type 2 (DM2) and fatty liver disease. DM2/IR are well known chronic form of metabolic disorders due to decline in insulin action leading to increased circulating levels of blood glucose. [1] [2] [3] With each passing day, prevalence of DM2 is increasing in our community as well as in the world. Approximately 1.3% population of the world is diabetic. 4, 5 According to IDF Diabetes Atlas, it was expected that in 2017 there are 451 million (age 18-99 years) people with diabetes worldwide. These figures were expected to increase to 693 million) by 2045. 6 Physical inactivity, fatty diet and diabetes are closely associated with nonalcoholic fatty liver disease (NAFLD). NAFLD is a fatty infiltration of liver cells involving sequelae of reversible steatosis, lobular steatohepatitis, hepatocytes ballooning to Hepatic Steatosis (HS) is a morphological pattern of liver injury that replaces healthy liver tissue Steatohepatitis develops in about 78% diabetic patients 8 while the ultrasonograhic examination of liver in many diabetic patients demonstrate fat in liver. 9 It has been focus of research because of is silent course in DM2 patients. 10, 11 Whether it is DM2 and NAFLD, Insulin resistance IR is considered as the main culprit. The resistance once developed leads to hyperglycemia and hyperinsulinemia, which stimulates lipid-accumulating processes and impairs fat metabolism in the liver. Free fatty acid (FFA) delivery to liver from the adipose tissue storage sites is increased due to continuous lipolysis. These changes result in HS which may induce Hepatic Insulin Resistance (HIR) and further aggravate the altered metabolic state of whole body which shows that there is a strong association between HS and IR. The whole body sensitivity to insulin decreases and at the same time fat accumulation in liver increases. 7, 12 Research on diabetes is still in search of the answers for complete treatment of diabetes. Therefore, anti-diabetic medicines are on and off evaluated for their effectiveness in controlling symptoms of the disease and minimizing side effects of the drugs. The most commonly advised drugs in diabetics are insulin and metformin. Insulin and metformin when used as a monotherapy seems to be less effective than insulin-metformin combination. The combination balances blood liver enzymes and keep blood glucose levels in normal range. 13 On other hand, insulin when used as monotherapy is harmful to liver because of its lipid metabolism (lipogenic effect) while metformin seems to have good results in fatty liver disease and diabetes. 14, 15 Keeping in view that insulin and metformin are most commonly prescribed medicines in diabetes, the current study was designed to evaluate the correlation between percent liver weight (PLW) and percent fat cells (PFC) in liver in HFD/STZ-induced diabetic models (treated and non-treated). Its also logical that in DM2 patients with uncontrolled blood glucose levels, monotherapy either with insulin and metformin is not desirable rather a combination therapy is more beneficial. The present study revealed the beneficial therapeutic results according to which the metformin and combination therapy (insulin and metformin) is more effective in fatty liver diseases. A significant positive correlation between PLW and PFCs was observed in Insulin treated rats which indicates insulin itself contributes to fat in liver.
METHODOLOGY Study Design
Experimental comparative study.
Sampling Method
Random.
Sample Size
Albino wistar rats (n= 50) weighing 160 ± 20g. 10 rats were housed in a single clear sided plastic cage. All rats were kept at room temperature and were given balanced diet and water ad libitum, before any dietary manipulation. Body weight of all rats were noted on a digital scale at the beginning of the experiment and weekly until sacrificed. Experimental induction of DM2 was done with a combination of high fat diet (HFD) and a single I.P injection of STZ. 8, 13 Experimentally (HFD/ STZ) induced rats were randomized into 4 groups: 1. Group A/ control Group (n=10). 2. Group E /Diabetic rats (n= 10). 3. Group B / Diabetic rats treated with insulin (n=10). 4. Group C/ Diabetic rats treated with metformin (n=10). 5. Group D /Diabetic rats treated with insulin metformin combination (n=10).
Group B was given Insulin (3U/kg/day), Group C was given metformin (200mg/kg/day) 16, 17 and group D was given Insulin-Metformin combination. 
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1210 3 percent weight of the liver was obtained by the formula: weight of liver/body weight of rat x 100. Liver was sectioned and placed in cassettes which were then immersed in 10% buffered formalin for 24-48hrs. Tissue was then stained with Hematoxylin and eosin stain and special stains to study the tissue from each group under light microscope. Each slide was examined by a single pathologist with hematoxylin and eosin sections for general hepatic morphology and Perodic-Acid Schiff (PAS) for fatty changes. Liver Steatosis was graded according to Brunt Score. 18 
Statistical Analysis
The collected data is analyzed by using SPSS version 22 .0. To analyze the direction and strength of the relationship between percent liver weight and percent liver cells, Pearson correlation is used for all the five experimental groups of rats.
RESULTS
There were 10 rat specimens in each group. Table-I shows mean values of the variables. As per Table II , the results indicate strong positive correlation between percent liver weight and percent liver cells for Group B (r = 0.841). The correlation score was found to be statistically significant (p-value < 0.01). For Group A and C, there is a weak negative correlation and for Group E moderate negative correlation (r = 0.484) has been observed. However, for all these groups A, C and E, the correlation is statistically non-significant (p-value > 0.01). There is a weak positive correlation between percent liver weight and percent fat cells for Group D nevertheless the correlation is statistically non-significant (p-value > 0.01). In general, the overall correlation indicates that only in case of insulin treated rats i.e. Group B, the percent fat cells in liver increases with increase in percent liver weight.
DISCUSSION
We have entered into an era of modernization in which our lives have become more comfortable and dependent on the machines. Other side of the picture shows more stress, unhealthy eating and physical inactivity. All these ill-habits have sown seeds for stress-related diseases like cardiovascular diseases, diabetes, fatty livers and many more. Out of many organs of the human body, liver is related to significant mortality and morbidity in diabetics. The current study focuses on analyzing the correlation between percent liver weight and percent fat cells the diabetic rat group treated with anti-diabetic medicines (insulin, metformin and insulin-metformin combination) and non-diabetic rat group. Diabetic patients have increased levels of liver enzymes, blood triglycerides and hepatic steatosis. 
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1211 4 After treatment phase, the livers were isolated and their PLW calculated. Moderate negative correlation has been observed in untreated diabetic rats. It might be because of decreased peripheral lipogenesis leading to increase in free fatty acids in liver when insulin is deficient. On the other hand, lipogenic pathways are activated in liver causing enlarged and fatty liver. 19 The present observations are consistent with current study. 20 Metformin, a well-known effective therapeutic agent as besides being an insulin sensitizer, it also reduces blood triglyceride levels and liver enzymes. 8, 21, 22 As IR is the common factor underlying DM2 and fatty liver disease, Metformin has promising role as being an insulin-sensitizer. 17 It works by decreasing hyperinsulinemia and also by inhibiting lipogenic enzymes which decreases hepatomegaly and consequently HIR and HS. 23, 24 In the present study, a weak negative correlation between PLW and PFCs is observed in metformin treated rats as the treatment reduced body weight, liver weight and fat cells in liver. The results are in agreement with previous studies conducted by Lingvay Insulin increases serum triglycerides and might be dangerous to liver. 8 In our study, rats given insulin showed reduced blood glucose levels, PLW and steatosis. A significant positive correlation between PLW and PFCs was noticed in insulin is seen suggesting that insulin is lipogenic. On the other hand, the rats treated with a combination of both insulin and metformin showed a weak negative correlation PLW and PFCs which suggests that insulin metformin combination is effective for diabetic patients as it improves liver steatosis and its triggering factors. Writing and proof reading manuscript. Writing and proof reading manuscript.
